Diabetes Clinical Trials in Chicago

Showing 61-80 of 662 trials

Allogenic Islet Cell Transplantation

NCT00160732

The purpose of this study is to determine the safety of transplanting human islet cells for controlling hyperglycemia in brittle and/or complex patients with type 1 diabetes. In addition, initial observations will be made with regards to the effectiveness of reversing hypoglycemia with this treatment. The "Edmonton Protocol" of using specific anti-rejection drugs without steroids is also being evaluated.

Diabetes Mellitus, Type 1

University of Chicago50 participantsStarted Oct 2003

Chicago, Illinois, United States

RECRUITINGNA2.2 miles

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

NCT06190717

This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.

DiabetesEnd Stage Renal Disease

Sonavex, Inc.304 participantsStarted Feb 2024

Dothan, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +17 more locations

Allogenic Islet Cell Transplantation

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

Diabetes Trials in Other Cities

A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes

Behavioral Chronotype: Impact on Sleep and Metabolism

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care

Multicenter Assessment of the Pancreas in Type 1 Diabetes

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

The Lifestyle Education About Nutrition for Diabetes (Legend) Study

A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

Effects of My Diabetes Care on Patient Outcomes

Other Conditions in Chicago